Mouthwash and oral care products against SARS-CoV-2
Article Sidebar
Main Article Content
Abstract
Covid-19 is an infectious disease of respiratory tract, transmitted by droplets and fomites, so there is a risk of disease transmission in dental clinic. Effective mouthwashes may reduce amount of viral load in oral cavity and have been recommended to use in dental patients by both national and international authorities since an early outbreak period. The article aimed to review basic knowledge and scientific evidences of using each type of mouthwashes to assist oral and maxillofacial surgeons and dentists to select proper mouthwashes and oral products.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The opinions and content expressed in the articles are solely those of the individual authors and do not necessarily reflect the views of the journal or the authors’ affiliated institutions. Authors are fully responsible for the accuracy and correctness of their work.
Any reuse, reproduction, or redistribution of the articles, content, data, or images in other forms requires prior written permission from the Thai Journal of Oral and Maxillofacial Surgery
References
Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cell of oral mucosa. Int J Oral Sci. 2020;12:8.
Carrouel F, Goncalves LS, Conte MP, Campus G, Fisher J, Fraticelli L, et al. Antiviral activity of reagents in mouth rinses against SARS-CoV-2. J Dent Res. 2021;100:121-32.
Pratelli A, Colao V. Role of the lipid rafts in the life cycle of canine coronavirus. J Gen Virol. 2015;96:331-7.
Siddharta A, Pfaender S, Vielle NJ, Dijhman R, Friesland M, becker B, et al. Viricidal activity of world health organization-recommended formulations against enveloped viruses, including Zika, Ebola, and emerging coronaviruses. J Infect Dis. 2017;215:902-6.
Yoon JG, Yoon J, Song JY, Yoon SY, Lim CS, Seong H, et al. Clinical significance of a high SARS-CoV-2 viral load in the saliva. J Korean Med Sci. 2020;35:e195.
Jain A, Grover V, Singh C, Sharma A, Das DK, Singh P, et al. Chlorhexidine: an effective anticovid mouth rinse.J Indian Soc Periodontol. 2021;25:86-8.
Steinhauer K, Meister TL, Todt D, Krawczyk TL, Passvogel L, Becker B, et al. Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 base on the European standard EN 14476. J Hosp Infect. 2021;111:180-3.
Chen MH, Chang PC. The effectiveness of mouthwash against SAR-CoV-2 infection: a review of scientific and clinical evidence. J Formos Med Assoc. 2020;121:879-55.
Guenezan J, Garcia M, Strasters D, Joussellin C, Leveque N, Frasca D, et al. Povidone iodine mouthwash, gargle, and nasal spray to reduce nasopharyngeal viral load in patients with COVID-19: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2021;147:400-1.
Mukherjee PK, Esper F, Buchheit K, Arters K, Adkins I, Ghannoum MA, et al. Ramdomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infection. BMC Infect Dis.2017;17:74.
Meyers C, Robinson R, Milici J, Alam S, Quillen D, Goldenberg D, et al. Lowering the transmission and spread of human coronavirus. J Med Virol. 2021;93:1065-12.
Komine A, Yamaguchi E, Okamoto N, Yamamoto K. Viricidal activity of oral care products against SARS- CoV-2 in vitro. J Oral Maxillofac Surg Med Pathol. 2021;33:475-7.
Mateos-Moreno MV, Mira A, Ausina-Marquez V, Ferrer MD. Oral antiseptics against coronavirus: in vitro and clinical evidence. J Hosp Infec. 2010;113:30-43.
Meister TL, Bruggemann Y, Todt D, Conzelmann C, Muller JA, GHross R, et al. Viricidal efficacy of different oral rinse against severe acute respiratory syndrome coronavirus 2. J Infect Dis. 2020;222:1289-92.
Vergara-Buenaventura A, Castro-Ruiz C. Use of mouthwashes against COVID-19 in dentistry. Brit J Oral Max Surg. 2020;58:924-7.